Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epidermolysis Bullosa, Dystrophic”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04186650
What this trial is testing

Ex Vivo Gene Therapy Clinical Trial for RDEB Using Genetically Corrected Autologous Skin Equivalent Grafts

Who this might be right for
Epidermolysis Bullosa Dystrophica, Recessive
Institut National de la Santé Et de la Recherche Médicale, France 3
Large-scale testing (Phase 3)Active Not RecruitingNCT06892639
What this trial is testing

Evaluation of D-Fi for the Treatment of Wounds Due to DEB

Who this might be right for
Dystrophic Epidermolysis Bullosa
Castle Creek Biosciences, LLC. 32
Not applicableLooking for participantsNCT01019148
What this trial is testing

Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa Dystrophica
Stanford University 70
Not applicableUnknownNCT06007235
What this trial is testing

CACIPLIQ20 in Wound Healing in Subjects With Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa, Junctional
Organ, Tissue, Regeneration, Repair and Replacement 16
Testing effectiveness (Phase 2)Looking for participantsNCT04173650
What this trial is testing

MSC EVs in Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis Bullosa
Aegle Therapeutics 8
Post-approval studies (Phase 4)Active Not RecruitingNCT07596927
What this trial is testing

Curcumin-Based Photodynamic Therapy in Epidermolysis Bullosa: Wound Healing, Quality of Life, and Salivary Biomarkers

Who this might be right for
Epidermolysis Bullosa (EB)Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa Acquisita
Universidade Ceuma 20
Large-scale testing (Phase 3)Active Not RecruitingNCT04213261
What this trial is testing

FCX-007 for Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Castle Creek Biosciences, LLC. 6
Not applicableStudy completedNCT01716169
What this trial is testing

Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care

Who this might be right for
Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa
Stanford University 10
Not applicableLooking for participantsNCT06423573
What this trial is testing

Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez

Who this might be right for
Epidermolysis Bullosa, DystrophicEpidermolysis Bullosa, Junctional
Amryt Pharma 580
Large-scale testing (Phase 3)Study completedNCT03928093
What this trial is testing

Pregabalin Treatment for RDEB Pain and Itch

Who this might be right for
Pain, NeuropathicItchEpidermolysis Bullosa
The Hospital for Sick Children 1
Not applicableStudy completedNCT03158662
What this trial is testing

Survey to Identify Burdens and Unmet Needs of Patients With Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa
Amicus Therapeutics 150
Not applicableLooking for participantsNCT07700966
What this trial is testing

A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Abeona Therapeutics, Inc 250
Not applicableNot Yet RecruitingNCT07684105
What this trial is testing

Treatment of Dysphagia in Patients With Dystrophic Epidermolysis Bullosa With Budesonide: a Retrospective Bicentric Study Nice - Paris St Louis / Necker (EBUDE Study)

Who this might be right for
Recessive Dystrophic Epidermolysis BullosaDysphagiaEsophageal Stenosis
Centre Hospitalier Universitaire de Nice 15
Not applicableLooking for participantsNCT04917887
What this trial is testing

Long-Term Follow-up Protocol

Who this might be right for
Dystrophic Epidermolysis BullosaRecessive Dystrophic Epidermolysis BullosaDominant Dystrophic Epidermolysis Bullosa
Krystal Biotech, Inc. 50
Large-scale testing (Phase 3)Ended earlyNCT00587223
What this trial is testing

Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)

Who this might be right for
Epidermolysis Bullosa, JunctionalEpidermolysis Bullosa Dystrophica
Organogenesis 1
Large-scale testing (Phase 3)Study completedNCT02384460
What this trial is testing

ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa
Scioderm, Inc. 169
Very early researchActive Not RecruitingNCT04171661
What this trial is testing

Self-Assembled Skin Substitute for the Treatment of Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa Dystrophica
CHU de Quebec-Universite Laval 1
Testing effectiveness (Phase 2)Study completedNCT04908215
What this trial is testing

INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa SimplexEpidermolysis Bullosa, JunctionalEpidermolysis Bullosa Dystrophica+1 more
InMed Pharmaceuticals Inc. 19
Not applicableStudy completedNCT01874769
What this trial is testing

Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Institut National de la Santé Et de la Recherche Médicale, France 30
Testing effectiveness (Phase 2)UnknownNCT05529134
What this trial is testing

Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene

Who this might be right for
Dystrophic Epidermolysis Bullosa
Phoenicis Therapeutics 8
Next Page